By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Probiodrug AG 

Weinbergweg 22

Halle (Saale)    D-06120  Germany
Phone: 49-345-5559900 Fax: 49-345-5559901


SEARCH JOBS








Company News
Probiodrug AG Funds Brigham and Women's Hospital Research Into Pyroglutamate-Abeta For The Treatment Of Alzheimer’s Disease 7/13/2015 8:37:10 AM
Probiodrug AG Reports First Quarter 2015 Business Update 5/13/2015 12:00:53 PM
Probiodrug AG Release: Key Patents On Glutaminyl Cyclase (QC) Inhibition For The Treatment Of Alzheimer’s Disease Granted In Japan 4/23/2015 9:11:39 AM
Probiodrug AG To Present Data On Its Anti-Pglu-3 Abeta Monoclonal Antibody At The 12th International Conference On Alzheimer’s And Parkinson’s Diseases (AD/PDTM 2015), Nice 3/20/2015 9:25:56 AM
Probiodrug AG Announces Enrolment Of First Patient In Phase 2 Study Of Novel Treatment For Alzheimer’s Disease 3/9/2015 10:35:50 AM
Probiodrug AG Release: Data On Glutaminyl Cyclases (Qcs) In Its Relation To Alzheimer’s Disease (AD) Published In Acta Neuropathologica 3/3/2015 7:52:36 AM
German Alzheimer's Drug Developer Probiodrug AG Plans Amsterdam IPO 9/29/2014 8:02:54 AM
Probiodrug AG Presents Pre-clinical And Clinical Findings Of PQ912, A QC-Inhibitor For Alzheimer's Disease 7/31/2014 11:47:53 AM
Probiodrug AG Presents Development Overview Of PQ912, Probiodrug’s QC-Inhibitor For Alzheimer’s Disease 7/10/2014 6:20:59 AM
Probiodrug AG To Present At 2014 Asia Biotech Invest Conference 6/2/2014 7:40:33 AM
1234
//-->